BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August

Day

• 2
• 3
• 4
• 5
• 6
• 9
• 10
• 11
• 12
• 13
• 16
• 17
• 18
• 19
• 20
• 23
• 24
• 25
• 26
• 27
• 30

• Press Releases

  MacroGenics to Present at the Goldman Sachs 46th Annual Global Healthcare Conference 2025

  June 4, 2025

   · 

  1 min read
• Press Releases

  U.S. FDA approves third indication of darolutamide for patients with advanced prostate cancer

  June 4, 2025

   · 

  6 min read
• Press Releases

  Xilio Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - June 3, 2025

  June 4, 2025

   · 

  1 min read
• Press Releases

  Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - June 3, 2025

  June 4, 2025

   · 

  2 min read
• Press Releases

  Ultragenyx to Participate at Goldman Sachs 46th Annual Global Healthcare Conference

  June 4, 2025

   · 

  1 min read
• Press Releases

  Travere Therapeutics to Present New FILSPARI® (sparsentan) Data at the 62nd ERA Congress

  June 4, 2025

   · 

  17 min read
• Press Releases

  Taysha Gene Therapies Announces Details for Oral Presentations at the 2025 IRSF Rett Syndrome Scientific Meeting Reviewing Recent Updates from the TSHA-102 Clinical Program

  June 4, 2025

   · 

  7 min read
• Press Releases

  Ascletis Announces Phase III Trial of Denifanstat (ASC40), a First-in-Class, Once-Daily Oral FASN Inhibitor for Acne, Meets All Endpoints

  June 4, 2025

   · 

  9 min read
• Press Releases

  Roche’s Evrysdi tablet approved by European Commission as first and only for Spinal Muscular Atrophy (SMA)

  June 4, 2025

   · 

  8 min read
• Press Releases

  IRLAB Participates in Aktiespararna’s Event - Aktiedagarna

  June 4, 2025

   · 

  1 min read